Virtus Investment Advisers’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$524K Buy
10,765
+2,860
+36% +$139K 0.18% 179
2025
Q1
$269K Buy
+7,905
New +$269K 0.07% 249